Archives

According to THE SAGE GROUP, Peripheral Artery Disease Afflicts 42 to 60 Million Chinese Citizens.

According to THE SAGE GROUP, Critical Limb Ischemia (CLI) is a Major and Growing Worldwide Problem.

According to THE SAGE GROUP, Undertreatment of Critical Limb Ischemia (CLI) and Chronic Venous Disease (CVD) Increases Costs.

According to THE SAGE GROUP, Peripheral Artery Disease (PAD) Afflicts 28 Million Western Europeans and 4.2 Million Suffer From Critical Limb Ischemia (CLI).

THE SAGE GROUP Releases New Estimates for the United States Prevalence, Incidence and Costs of Chronic Venous Disese (CVD), Varicose Veins and Venous Ulcers.

THE SAGE GROUP Releases New Estimates for the United States Prevalence and Incidence of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI).

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP LLC Comments on the Economic Burden of the Disease.

THE SAGE GROUP Announces that Mary L. Yost, President, Will Present Several Lectures on Peripheral Artery Disease (PAD), Critical Limb Ischemia (CLI) and Amputation at the 17th Annual NEW CARDIOVASCULAR HORIZONS (NCVH) Meeting.

September is Peripheral Artery Disease (PAD) Awareness Month; THE SAGE GROUP Highlights PAD Costs and Consequences.

THE SAGE GROUP Announces that Mary L. Yost, President, Will Lecture at the NEW CARDIOVASCULAR HORIZONS (NCVH) Second Annual “Understanding the Business of Peripheral Interventions” Session.

THE SAGE GROUP Announces that Mary L. Yost, President, Will Lecture at the NEW CARDIOVASCULAR HORIZONS (NCVH) Inaugural Economic Session “Understanding the Business of Peripheral Interventions.”

According to THE SAGE GROUP, 4-5 million People in Mexico Suffer from Peripheral Artery Disease.

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Peripheral Arterial Disease (PAD) at the 2014 National Congress of Angiology and Vascular Surgery in Mexico.

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Disease.

THE SAGE GROUP Estimates the Economic Cost of Critical Limb Ischemia Amputations at $25 Billion.